1·Objective to construct recombinant adenovirus vector carrying human TRADD gene.
目的构建含有人TRADD基因片段的重组腺病毒载体。
2·Conclusion Lentiviral vector carrying BMP-7 gene has been successfully constructed and maintains high expression in HSC-T6 cells.
结论成功构建了带有大鼠bmp - 7基因的慢病毒载体，并实现其在HSC - T6的稳定高表达。
3·AIM: to construct a recombinant adenovirus vector carrying AFP promoter to specifically express a targeting gene in hepatocellular carcinoma HepG2 cells.
目的：建立一种在甲胎蛋白(afp)阳性的肝癌细胞中靶向表达目的基因的重组腺病毒载体。
4·AIM: to construct eukaryotic expression vector carrying human antisense VEGF gene and to study its effect on VEGF expression and growth of renal cell carcinoma.
目的：构建反义vegf基因真核表达载体，研究其对肾癌细胞VEGF表达的影响。
5·Objective: To construct a replication-competent adenovirus vector carrying human endostatin gene, looking for an effective method for the therapy of colon cancer.
目的：构建携带内皮抑素基因的增殖型腺病毒载体，寻找结肠癌的有效治疗方法。
6·Objective:To construct a recombinant defective retroviral vector carrying hNT3 gene and a stable virus-producing packaging cell lines , and then to identify them.
构建并鉴定携带人NT - 3基因的逆转录病毒载体以及稳定的包装细胞系。
7·Objective to construct a recombinant adenovirus vector carrying antisense heat shock protein 70 (HSP70) cDNA and observe its effect on inhibiting the growth of laryngeal carcinoma Hep-2 cells.
目的构建携带反义热休克蛋白70 (HSP70)的重组腺病毒载体以用于喉癌的基因治疗研究。
8·AIM: to construct the recombinant adenoviral vector carrying antisense RNA to chemokine receptors CCR5 and CXCR4 and to obtain recombinant adenovirus, which will be used to resist HIV 1 infection.
目的：构建趋化因子受体c CR 5, CXCR4双靶区反义rna重组载体并获取重组腺病毒以用于抗hiv 1基因治疗的研究。
9·Conclusion the recombinant adenovirus vector carrying human TRADD gene was successfully constructed. It can be used for detecting the effects of TRADD on fibroblasts of hypertrophic scar and keloid.
结论构建成功的含有TRADD基因片段的重组腺病毒，可用于转染人成纤维细胞，用于检测TRADD对病理性瘢痕成纤维细胞的影响。
10·Two kinds of information carrying schemes for vector quantization are designed, and the experimental results of different cases are compared.
针对向量量化这种常用的图象压缩方法，设计了两类信息搭载方案，并对参数取值的不同情况进行了实验比较。